statistiche ricercatore

TOSI, GIOVANNA

Distribuzione geografica

Continente	#
NA - Nord America	9.940
EU - Europa	8.501
AS - Asia	4.081
SA - Sud America	461
AF - Africa	50
Continente sconosciuto - Info sul continente non disponibili	8
OC - Oceania	4
Totale	23.045

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	9.761
IT - Italia	4.320
UA - Ucraina	1.555
SG - Singapore	1.346
CN - Cina	718
VN - Vietnam	674
TR - Turchia	648
DE - Germania	580
SE - Svezia	576
HK - Hong Kong	510
FI - Finlandia	428
BR - Brasile	414
IE - Irlanda	298
RU - Federazione Russa	242
GB - Regno Unito	221
FR - Francia	134
CA - Canada	122
IN - India	50
MX - Messico	46
PL - Polonia	38
JP - Giappone	36
BE - Belgio	32
ZA - Sudafrica	24
ES - Italia	21
AR - Argentina	18
BD - Bangladesh	17
NL - Olanda	15
IQ - Iraq	13
KR - Corea	11
PK - Pakistan	10
LT - Lituania	9
MA - Marocco	9
AE - Emirati Arabi Uniti	8
EU - Europa	8
CH - Svizzera	7
EC - Ecuador	7
IR - Iran	7
CZ - Repubblica Ceca	6
VE - Venezuela	6
ID - Indonesia	5
SA - Arabia Saudita	5
UZ - Uzbekistan	5
CO - Colombia	4
KE - Kenya	4
LB - Libano	4
PY - Paraguay	4
TN - Tunisia	4
TW - Taiwan	4
AT - Austria	3
BY - Bielorussia	3
DZ - Algeria	3
JM - Giamaica	3
PE - Perù	3
RS - Serbia	3
AU - Australia	2
BH - Bahrain	2
CI - Costa d'Avorio	2
CL - Cile	2
GR - Grecia	2
HR - Croazia	2
IL - Israele	2
MT - Malta	2
NZ - Nuova Zelanda	2
TT - Trinidad e Tobago	2
UY - Uruguay	2
AO - Angola	1
BB - Barbados	1
CR - Costa Rica	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EG - Egitto	1
GA - Gabon	1
GY - Guiana	1
HN - Honduras	1
KH - Cambogia	1
KW - Kuwait	1
KZ - Kazakistan	1
ME - Montenegro	1
MK - Macedonia	1
NO - Norvegia	1
PA - Panama	1
PH - Filippine	1
PR - Porto Rico	1
PS - Palestinian Territory	1
QA - Qatar	1
TG - Togo	1
Totale	23.045

Salva come PNG Salva come JPEG

Città	#
Milan	3.337
Jacksonville	1.193
Fairfield	928
Chandler	783
Ashburn	724
Singapore	698
Woodbridge	609
Hong Kong	509
Wilmington	429
Ann Arbor	424
Houston	407
Izmir	406
Princeton	398
Seattle	389
Dearborn	366
Beijing	328
Nyköping	297
Dublin	296
Cambridge	287
Dallas	284
Dong Ket	268
Boardman	235
Rome	231
San Mateo	138
The Dalles	121
New York	112
Los Angeles	93
Como	91
Toronto	85
San Diego	76
Ogden	69
Munich	53
Santa Clara	50
São Paulo	50
Düsseldorf	45
Chicago	43
Helsinki	35
Tokyo	35
Hefei	34
Verona	33
Ho Chi Minh City	32
Warsaw	32
Brussels	31
London	29
Nanjing	28
Hanoi	27
Mexico City	26
Norwalk	25
Council Bluffs	23
Guangzhou	22
Turku	22
Boston	21
Frankfurt am Main	20
Phoenix	20
Pune	20
Kunming	19
Orem	19
Brooklyn	17
Falls Church	17
Johannesburg	17
Manchester	17
Jinan	16
Stockholm	16
Washington	16
St Petersburg	15
Columbus	14
Denver	14
Montreal	14
Chennai	13
Fuzhou	13
San Francisco	13
Belo Horizonte	11
Poplar	10
Amsterdam	9
Kocaeli	9
Atlanta	8
Brasília	8
Buffalo	8
Curitiba	8
Hangzhou	8
Kilburn	8
Nanchang	8
Nuremberg	8
Porto Alegre	8
Rio de Janeiro	8
Shanghai	8
Changsha	7
Hebei	7
Querétaro	7
Raleigh	7
Salt Lake City	7
Tehran	7
Xian	7
Auburn Hills	6
Chongqing	6
Guarulhos	6
Shenyang	6
Wuhan	6
Zhengzhou	6
Charlotte	5
Totale	15.834

Salva come PNG Salva come JPEG

Nome	#
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	237
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	225
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	225
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	202
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	199
A girl with Diabetes and severe Combined Immunodeficiency from Adenosine Deaminase Deficiency	194
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.	193
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	192
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	187
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	184
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	184
The MHC class II transactivator: prey and hunter in infectious diseases	182
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	180
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy	176
Picosecond-resolved FRET on non-amplified DNA for identifying individuals genetically susceptible to type-1 diabetes	175
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	174
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA	172
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	172
Autoimmunità e Malattie Autoimmuni	172
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	168
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	166
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis	165
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	163
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	162
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	160
Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM	160
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	155
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment	155
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naÃ¯ve tumor-specific CD4+ T cells	155
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma	153
Insight into the molecular mechanism of CIITA-mediated inhibition of HIV-1 and HTLV transactivators	152
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle	151
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	151
A dual defensive role of CIITA against retroviral infections	150
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.	150
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines	150
Distinct regulation of HLA class II and class I cell surface expression in THP-1 macrophage cell line after bacterial phagocytosis	148
HLA-DQ genotype in early onset insulin dependent diabetes mellitus	147
Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters	146
MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?	146
Associazione tra genotipo HLA-DQ e suscettibilità al Diabete insulino-Dipendente	146
Block of Stat-1 activation in macrophages, undergoing bacterial phagocytosis causes CIITA reduced transcription and consequent impaired antigen presentation	145
Time-Resolved Förster Resonance Energy Transfer Analysis of Single-Nucleotide Polymorphisms: Towards Molecular Typing of Genes on Non-Purified and Non-PCR-Amplified DNA	145
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR	143
Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers	143
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization	143
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells	142
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes	142
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	140
New approaches of cancer vaccination and cancer immunotherapy based on the optimal stimulation of tumor-specific, MHC class II-restricted CD4+ T helper cells	140
CIITA dependent MHC class II IA expression in tumor cells triggers CD4 T cell protective and long lasting antitumor immunity	139
Analysis of a combined immunodeficiency patient with defect in MHCII expression (BLS) reveals the presence of several mutant isoforms of RFXANK mRNA	138
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication.	137
The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein	137
Analysis of microchimerism in thyroid autoimmune diseases	136
Role of the HLA-DQ genotype in IDDM susceptibility	135
Tax-1-mediated HTLV-1 replication and NF-kB activation is inhibited by the MHC-II transactivator CIITA	135
Apparente dissociazione tra fenotipo DR e genotipo MHC di classe II in IDDM	134
Tax-1-mediated NF-kB activation is inhibited by the MHC-II transactivator CIITA	134
The complex interplay of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for Insulin-Dependent Diabetes Mellitus	134
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1	133
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein	133
Tat protein is an HIV-1 encoded SS-chemochine homolog that promotes migrationand upregulates CCR3 on human FceRI+ cells	129
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis	129
Distinct subcellular localization of HTLV-1 HBZ oncoprotein in the ATL leukemic and HAM/TSP patients.	129
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	128
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas	128
Molecular typing of polymorphic genes by time-resolved fluorescence resonance energy transfer	128
HLA-DQB1 typing of north east italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-Enzyme Immunoassay (DEIA)	128
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1B molecules after mycobacterial phagocytosis	128
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication	128
HTLV-2 Tax-2 transactivator increases the expression and the function of its inhibitor CIITA, the master regulator of HLA-II gene transcription	127
The MHC Class II transactivator, CIITA,is a viral restriction factor for human oncogenic retroviruses	124
CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication	124
Cellular and molecular aspects of immune response relevant to autoimmune diseases	124
Associazione tra HLA-DQB1 e diabete giovanile analizzata a livello molecolare per Southern e DEIA	123
Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines	123
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	123
CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis	122
The constitutive activation of NF-kB by HTLV-1 Tax-1 oncoprotein is inhibited by the MHC class II transactivator CIITA	122
Host-retrovirus interaction: role of CIITA in the inhibition of HTLV-1 replication and oncogenic potential	121
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	120
A new strategy of tumor vaccination based on tumor cells transduced with the MHC class II transactivator CIITA	119
The MHC class II transactivator, CIITA, blocks the transcriptional activity of both HTLV-2 Tax-2 and HTLV-1 Tax-1	118
The MHC class II transactivator (CIITA): a physiologic inhibitor of HIV1 and HTLV2 retroviral infections	117
HTLV2 influence on pathways regulating proliferation and death in B cell line BJAB	117
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan	116
Efficient antigen presentation and T cell activation by MHC class II molecules of CIITA-transfected epatocarcinoma cells	116
Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope associated HLA class II molecules reverse this effect	115
Control of mammary adenocarcinoma growth in vivo by gene therapy with the MHC class II transactivator CIITA	114
Regulation of HLA antigen expression in HIV infected cells	114
Evidence for a specific post- transcriptional mechanism controlling the expression of HLA-DQ, but not DR and DP molecules	113
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	113
CIITA, the Master Regulator of MHC Class II Gene Transcription, Targets the Viral Transactivator Tax-1 to Inhibit HTLV-I Viral Replication and NFKB Activation	112
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication	112
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	112
Approcci immunogenetici per il controllo dell'infezione da retrovirus umani	112
The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (CIITA)	111
The MHC class II transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection.	111
HTLV-II Tax-2 increases the cell surface expression of HLA-II molecules by acting at the level of CIITA, the master regulator of HLA-II transcription	110
Totale	14.492

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	91.633
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	91.633

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.949	0	0	0	0	0	272	83	287	431	102	242	532
2021/2022	1.700	211	223	152	133	42	48	57	123	83	222	159	247
2022/2023	2.159	252	86	120	258	159	493	0	292	312	63	69	55
2023/2024	4.884	816	801	919	824	877	310	50	40	155	20	9	63
2024/2025	2.562	10	45	483	50	107	108	123	141	313	158	220	804
2025/2026	2.571	492	363	187	862	539	128	0	0	0	0	0	0
Totale													23.111